¹ÙÀÌ¿À¹ðÅ© ½ÃÀå - ¼¼°è ¹× Áö¿ªº° ºÐ¼® : Á¦Ç° ¹× ¼­ºñ½º, º¸°ü À¯Çü, »ùÇà À¯Çü, ¼ÒÀ¯ÀÚ, ¹ÙÀÌ¿À¹ðÅ© À¯Çü, ¿ëµµ, ±¹°¡, Áö¿ªº° ºÐ¼®°ú ¿¹Ãø(2025-2035³â)
Biobanking Market - A Global and Regional Analysis: Focus on Product and Service, Storage Type, Sample Type, Ownership, Biobank Type, Application, Country, and Region - Analysis and Forecast, 2025-2035
»óǰÄÚµå : 1811800
¸®¼­Ä¡»ç : BIS Research
¹ßÇàÀÏ : 2025³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,900 £Ü 6,943,000
PDF and Excel (1-3 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 3¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,628,000
PDF and Excel (Global License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹ÙÀÌ¿À¹ðÅ· ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù.

À¯ÀüüÇÐ ¹× »ý¸í°øÇÐÀÇ ¹ßÀü¿¡ µû¶ó ȯÀÚ °³°³ÀÎÀÇ À¯ÀüÁ¤º¸¸¦ ±â¹ÝÀ¸·Î ÀǷḦ ÃÖÀûÈ­ÇÏ·Á´Â ¿òÁ÷ÀÓÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À¹ðÅ©´Â ´Ù¾çÇÑ »ý¹°ÇÐÀû »ùÇÃÀ» º¸Á¸ÇÔÀ¸·Î½á À¯ÀüÀû º¯ÀÌ¿Í ±× °Ç°­ ¹× Áúº´¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ±Ô¸íÇϰí, º¸´Ù È¿°úÀûÀÌ°í ºÎÀÛ¿ëÀÌ ÀûÀº Ç¥Àû Ä¡·áÁ¦ ¹× Ä¡·á¹ýÀ» °³¹ßÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.

¶ÇÇÑ ¾Ï, ´ç´¢, ½ÉÇ÷°üÁúȯ µî ¸¸¼ºÁúȯÀÇ Áõ°¡µµ ¹ÙÀÌ¿À¹ðÅ©ÀÇ Çʿ伺À» ³ôÀ̰í ÀÖ½À´Ï´Ù. »ý¹°ÇÐÀû ¹°ÁúÀÇ ÀúÀå¼Ò¸¦ Á¦°øÇÔÀ¸·Î½á ¿¬±¸ÀÚµéÀº Áúº´ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°Çϰí, Áúº´ ¸ÞÄ¿´ÏÁòÀ» ÀÌÇØÇϰí, »õ·Î¿î Áø´Ü ¹× Ä¡·á¹ýÀ» °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á°¡ Çö´ë ÀÇ·áÀÇ Áß½ÉÃàÀ¸·Î ÀÚ¸® ÀâÀ¸¸é¼­ °íǰÁú »ý¹°ÇÐÀû »ùÇÃÀ» Á¦°øÇÏ´Â ¹ÙÀÌ¿À¹ðÅ©¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

¹ÙÀÌ¿À¹ðÅ· ½ÃÀåÀÌ °è¼Ó ¼ºÀåÇϰí ÀÖÁö¸¸, ¸î °¡Áö °úÁ¦´Â ¿©ÀüÈ÷ Á¸ÀçÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä °úÁ¦ Áß Çϳª´Â »ý¹°ÇÐÀû »ùÇÃÀÇ ¼öÁý, º¸°ü, À̿뿡 µû¸¥ À±¸®Àû, ¹ýÀû ¹®Á¦ÀÔ´Ï´Ù. »çÀü µ¿ÀÇ, ÇÁ¶óÀ̹ö½Ã, ±âÁõÀÚ Á¤º¸ ±â¹Ð À¯Áö µîÀÇ ¹®Á¦´Â ¿©ÀüÈ÷ Å« °úÁ¦ÀÔ´Ï´Ù. ƯÈ÷ À¯ÀüÁ¤º¸¿Í °°Àº ¹Î°¨ÇÑ µ¥ÀÌÅ͸¦ ´Ù·ç´Â °æ¿ì, ½Ã·á Á¦°øÀÚ°¡ ÃæºÐÈ÷ ÀÌÇØÇÑ ÈÄ µ¿ÀǸ¦ Çϰí, ±× ÇÁ¶óÀ̹ö½Ã°¡ È®½ÇÈ÷ º¸È£µÇ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

¶ÇÇÑ, Áö¿ªÀ̳ª ±â°ü¿¡ µû¶ó ¹ÙÀÌ¿À¹ðÅ·¿¡ ´ëÇÑ ±ÔÁ¦³ª Ç¥ÁØÈ­°¡ ÅëÀϵǾî ÀÖÁö ¾Ê¾Æ µ¥ÀÌÅÍ Ç°Áú, ½Ã·áÀÇ Ãë±Þ, º¸°ü ¹æ½Ä¿¡ Â÷À̰¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç¥ÁØÈ­ÀÇ ºÎÀç´Â ¿¬±¸±â°ü °£ µ¥ÀÌÅÍ °øÀ¯¿Í Çù·ÂÀ» º¹ÀâÇÏ°Ô ¸¸µé°í, ¹ÙÀÌ¿À¹ðÅ© ÀÚ¿øÀÇ ¼¼°è À¯¿ë¼ºÀ» Á¦ÇÑÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¸¶Áö¸·À¸·Î, ¹ÙÀÌ¿À¹ðÅ©ÀÇ À¯Áö¿¡´Â ÀçÁ¤Àû, ÀÎÇÁ¶óÀû ¹®Á¦°¡ ÀÖ½À´Ï´Ù. ¹æ´ëÇÑ µ¥ÀÌÅÍ¿Í »ùÇÃÀ» Àå±â°£ °ü¸®Çϱâ À§Çؼ­´Â º¸°ü ½Ã¼³°ú °°Àº ¹°¸®Àû ÀÎÇÁ¶ó¿Í À̸¦ ¿î¿ëÇÏ´Â ±â¼ú¿¡ ´ëÇÑ ´ë±Ô¸ð ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù.

¼¼°è ¹ÙÀÌ¿À¹ðÅ· ½ÃÀå¿¡¼­ °¡Àå Áß¿äÇÑ ½ÅÈï Æ®·»µå Áß Çϳª´Â µðÁöÅÐ ±â¼ú°ú ÀÚµ¿È­ÀÇ ÅëÇÕÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â °í±Þ µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛ, AI ±â¹Ý Ç÷§Æû, ½Ã·áÀÇ ¼öÁý, º¸°ü, ºÐ¼®ÀÇ ÀÚµ¿È­ µµÀÔ°ú ÇÔ²² ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¹ÙÀÌ¿À¹ðÅ· ¾÷¹«ÀÇ È¿À²¼º, Á¤È®¼º, È®À强À» ³ôÀÌ°í ´ë·®ÀÇ »ý¹°ÇÐÀû »ùÇÃÀ» º¸´Ù ½±°Ô °ü¸®ÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀÚµ¿È­´Â ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­Çϰí, ÀÎÀ§ÀûÀÎ ¿À·ù¸¦ ÁÙÀ̰í, ½Ã·á Ãë±ÞÀÇ ½Å·Ú¼ºÀ» ³ô¿© ½Ã·áÀÇ ¹«°á¼ºÀ» À¯ÁöÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¶ÇÇÑ, µðÁöÅÐ µµ±¸´Â ¼­·Î ´Ù¸¥ ¿¬±¸ ½Ã¼³°ú Áö¿ª¿¡ °ÉÃÄ ½Ã·áÀÇ ÃßÀû ¹× °ü¸®¸¦ °³¼±Çϰí, Àü ¼¼°è ¹ÙÀÌ¿À¹ðÅ© ³×Æ®¿öÅ© °£ÀÇ µ¥ÀÌÅÍ °øÀ¯ ¹× Çù·ÂÀ» º¸´Ù È¿À²ÀûÀ¸·Î ÃËÁøÇÕ´Ï´Ù. °íǰÁúÀÇ Ã¼°èÀûÀ¸·Î Á¤¸®µÈ »ý¹°ÇÐÀû »ùÇÿ¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó, ÀÌ·¯ÇÑ Ãß¼¼´Â ¾ÕÀ¸·Îµµ ¹ÙÀÌ¿À¹ðÅ· »ê¾÷ Çü¼º¿¡ ¿µÇâÀ» ¹ÌÃÄ ¸ÂÃãÇü ÀÇ·á, À¯ÀüüÇÐ, ½Å¾à°³¹ßÀÇ ÁøÀüÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ· ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ÁÖ¿ä µ¿Çâ, ½ÃÀå ¿µÇâ¿äÀÎ ºÐ¼®, ¹ý¡¤±ÔÁ¦ ȯ°æ, ±â¼ú¡¤Æ¯Ç㠺м®, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¦1Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ© ½ÃÀå : ¾÷°è Àü¸Á

Á¦2Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ© ½ÃÀå : Á¦Ç° ¹× ¼­ºñ½ºº°

Á¦3Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ© ½ÃÀå : º¸°ü À¯Çüº°

Á¦4Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ© ½ÃÀå : »ùÇà À¯Çüº°

Á¦5Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ© ½ÃÀå : ¼ÒÀ¯ÀÚº°

Á¦6Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ© ½ÃÀå : ¹ÙÀÌ¿À¹ðÅ© À¯Çüº°

Á¦7Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ© ½ÃÀå : ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ© ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ© ½ÃÀå : Áö¿ªº°

Á¦10Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¹ðÅ© ½ÃÀå : °æÀï ±¸µµ¡¤±â¾÷ °³¿ä

Á¦11Àå Á¶»ç ¹æ¹ý

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Biobanking Market, Analysis and Forecast: 2025-2035

Biobanking refers to the process of collecting, storing, and managing biological samples (such as blood, tissue, DNA, RNA, and other bodily fluids) for research and medical purposes. These samples are preserved and catalogued in biorepositories or biobanks, where they are stored under controlled conditions to maintain their integrity for long-term use. Biobanks are invaluable resources for scientific research, particularly in fields like genomics, cancer research, drug development, and epidemiology.

Researchers use biobanks to investigate the genetic and environmental factors that contribute to diseases, understand disease mechanisms, and develop personalized treatments. Biobanks are also used for testing the efficacy of new medications, understanding population health trends, and advancing medical knowledge. With the growing focus on precision medicine, biobanks are becoming increasingly important as they provide high-quality biological samples that are essential for creating tailored healthcare solutions based on individual genetic profiles.

One of the key drivers of the biobanking market is the increasing demand for personalized medicine. As advancements in genomics and biotechnology continue to progress, there is a growing focus on tailoring medical treatments to individual patients based on their genetic makeup. Biobanks play a critical role in this area by storing diverse biological samples that can be used to understand genetic variations and their implications on health and disease. These samples help researchers develop targeted therapies and treatments that are more effective and less harmful to patients.

The rise in chronic diseases, such as cancer, diabetes, and cardiovascular conditions, further drives the need for biobanks. By providing a repository of biological materials, biobanks enable researchers to identify disease biomarkers, understand disease mechanisms, and develop new diagnostic and therapeutic methods. As personalized medicine becomes a central pillar of modern healthcare, the demand for biobanks and high-quality biological samples is expected to continue to grow.

Despite the growth of the biobanking market, several challenges persist. One of the primary challenges is the ethical and legal concerns associated with the collection, storage, and use of biological samples. Issues surrounding informed consent, privacy, and confidentiality of donor information remain a significant challenge. Ensuring that individuals provide informed consent for the use of their biological samples in research and that their privacy is protected is crucial, especially when dealing with sensitive genetic data.

Furthermore, the lack of uniform regulations and standardization in biobanking practices across different regions and institutions can lead to discrepancies in data quality, sample handling, and storage methods. This lack of standardization complicates data sharing and collaboration among research institutions, which can limit the global utility of biobank resources.

Lastly, there are financial, and infrastructure challenges related to maintaining biobanks, as they require significant investment in both the physical infrastructure (such as storage facilities) and technology to manage vast amounts of data and biological samples over extended periods.

The global Biobanking market is highly competitive, with major players such as Becton, Dickinson and Company, QIAGEN N.V., Merck KGaA, Thermo Fisher Scientific Inc., PHC Holdings Corporation, Cryoport, Inc., Azenta, Inc., Avantor, Inc., Tecan Trading AG, Greiner AG, Bay Biosciences LLC, Shanghai Zhangjiang Biobank, US Biolab Corporation, Inc., Cureline, and Brooks Life Sciences leading the way. These companies are continuously innovating and expanding their product portfolios to cater to the growing demand for biological sample storage, processing, and management in research, personalized medicine, and drug development.

The competition in the market is driven by advancements in technology, improvements in storage capabilities, and the increasing need for high-quality biological samples for clinical trials, genomic research, and disease study. With significant investments in infrastructure, digitalization, and regulatory compliance, these key players are well-positioned to shape the future of the biobanking market.

Biobanking Market Segmentation:

Segmentation 1: by Product and Service

Segmentation 2: by Storage Type

Segmentation 3: by Sample Type

Segmentation 4: by Ownership

Segmentation 5: by Biobank Type

Segmentation 6: by Application

Segmentation 7: by End User

Segmentation 8: by Region

One of the most significant emerging trends in the global biobanking market is the integration of digital technologies and automation. This trend involves the adoption of advanced data management systems, AI-driven platforms, and automation in sample collection, storage, and analysis. These technologies improve the efficiency, accuracy, and scalability of biobanking operations, making it easier to manage large volumes of biological samples. Automation helps streamline processes, reduces human error, and enhances the reliability of sample handling, which is crucial for maintaining sample integrity.

Moreover, digital tools enable better tracking and management of samples across different research facilities and regions, promoting more efficient data sharing and collaboration between global biobank networks. With the growing demand for high-quality and well-organized biological samples, this trend is expected to continue to shape the biobanking industry, supporting advancements in personalized medicine, genomics, and drug development.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Biobanking Market: Industry Outlook

2. Global Biobanking Market (by Product and Service), ($Billion), 2024-2035

3. Global Biobanking Market (by Storage Type), ($Billion), 2024-2035

4. Global Biobanking Market (by Sample Type), ($Billion), 2024-2035

5. Global Biobanking Market (by Ownership), ($Billion), 2024-2035

6. Global Biobanking Market (by Biobank Type), ($Billion), 2024-2035

7. Global Biobanking Market (by Application), ($Billion), 2024-2035

8. Global Biobanking Market (by End User), ($Billion), 2024-2035

9. Global Biobanking Market (by Region), ($Billion), 2024-2035

10. Global Biobanking Market: Competitive Landscape and Company Profiles

11. Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â